需要支持:促进心脏性休克患者早期转移到高级心力衰竭中心
Vicki N Wang1,2, Darshan H Brahmbhatt1,2, Julie K K Vishram-Nielsen2,3
1Division of Cardiology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
CJC open
|November 25, 2024
概括
转移用于心脏性休克 (CS) 护理的患者年轻,需要更密集的支持,但死亡率较低. 这表明在CS管理中,设施间转移的结果有所改善.
科学领域:
- 心脏病学 心脏病学
- 密集护理医学 密集护理医学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 心脏性休克 (CS) 是一种需要迅速医疗干预的危急状况.
- 了解患者的途径,包括设施间的转移,对于优化CS护理至关重要.
- 将从外部医院转移的患者的结果与直接进入专门中心的患者的结果进行比较,可以提供有价值的见解.
研究的目的:
- 评估心脏性休克 (CS) 患者的临床特征.
- 为了比较从外部医院转移的CS患者的结果与直接入院到心脏重症监护室的患者的结果.
- 确定影响耐用心室辅助器件,心脏移植或死亡的复合终点的因素.
主要方法:
- 在2014年1月1日至2019年12月31日期间接受CS治疗的916名患者的回顾性分析.
- 转移患者和直接入院患者之间的临床特征和结果的比较.
- 多变量分析,以评估达到复合终点的可能性.
主要成果:
- 转移的患者年轻,需要更多的血管压力器和机械呼吸,并且更频繁地需要体外生命支持.
- 直接入院的患者有更高的心脏移植率.
- 转移的患者表现出较低的全因死亡率,并且不太可能达到复合终点 (HR 0.75,P = 0.003).
结论:
- 从外部设施转移的心脏性休克患者与直接入院的患者之间的特征和结果存在显著差异.
- 从外部机构转移与更好的结果有关,包括降低死亡率.
- 需要进一步的研究来完善转移决策和评估标准化的CS协议.
相关概念视频
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:26Imbalances in Cardiac Output
1.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
386
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
386
01:17Aortic Regurgitation IV: Nursing Management
12
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
12
01:22Heart Failure Drugs: β-Blockers
316
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
316